| |
Control
|
RNAi
|
---|
| |
Mock (%)
|
Scramble (%)
|
SRCAP A (%)
|
SRCAP B (%)
|
---|
Metaphase
|
MS
|
4.38 ± 2.58
|
0
|
6.21 ± 4.43
***(scramble)
|
0
|
CM
|
15.31 ± 14.45
|
3.30 ± 5.80
|
57.36 ± 16.78***
|
47.90 ± 5.90***
|
ASM
|
2.25 ± 0.45
|
0
|
29.93 ± 2.80***
|
20.8 ± 5.90***
|
Telophase
|
CB
|
6.00 ± 1.97
|
1.00 ± 1.70
|
8.45 ± 4.96
*(mock), ***(scramble)
|
38.20 ± 3.60***
|
LIB
|
1.87 ± 0.67
|
8.10 ± 1.10
|
28.69 ± 9.21**
|
23.80 ± 3.60***
|
MC
|
2.16 ± 0.49
|
1.90 ± 1.70
|
14.21 ± 3.74***
|
9.30 ± 2.30***
|
- CB, chromatin bridges; CM, chromosome misalignments; LIB, long intercellular bridges; MC, multinucleated cells; MS, multipolar Spindles
- The results are expressed as mean ± SD values from three independent replicate experiments: *P < 0.05; **P < 0.005; and ***P < 0.0005 compared with the controls group by Fisher’s exact test
- Notably, MS found in cells treated with SRCAP A are statistically significant (***) compared to scramble, but not to mock. CB show different statistically significant levels depending on comparison between SRCAP A and scramble (***) or mock (*)